e-NIOS Overview
- Year Founded
-
2013

- Status
-
Private
- Employees
-
8

- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$25.5K
- Investors
-
3
e-NIOS General Information
Description
Operator of genomic data analysis and interpretation platform designed to automate biomarker discovery for precision medicine. The company's platform offers an unsupervised analysis of complex genomic, and multi-omic data, and accelerates the discovery of critical biomarkers, and the technology incorporates biological knowledge into data mining, enabling researchers to deliver novel molecular markers or targets for diagnostics and therapeutics.
Contact Information
Website
www.e-nios.comCorporate Office
- L. Syggrou 196
- Kallithea
- Athens, Attiki 176 71
- Greece
Corporate Office
- L. Syggrou 196
- Kallithea
- Athens, Attiki 176 71
- Greece
e-NIOS Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Accelerator/Incubator | 28-Jul-2022 | $25.5K | Completed | Generating Revenue | ||
2. Seed Round | 01-Jan-2017 | Completed | Generating Revenue | |||
1. Seed Round | 14-Dec-2015 | $215K | $215K | Completed | Generating Revenue |
e-NIOS Comparisons
Industry
Financing
Details
e-NIOS Competitors (3)
One of e-NIOS’s 3 competitors is SOPHiA GENETICS, a Formerly VC-backed company based in Rolle, Switzerland.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
SOPHiA GENETICS | Formerly VC-backed | Rolle, Switzerland | ||||
Qiagen | Formerly VC-backed | Hilden, Germany | ||||
Roche Diagnostics | Corporation | Rotkreuz, Switzerland |
e-NIOS Patents
e-NIOS Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3861022-A1 | Methods and pharmaceutical composition for the treatment of mucosal inflammatory diseases | Pending | 04-Oct-2018 | ||
JP-2022512626-A | Methods and pharmaceutical compositions for the treatment of mucosal inflammatory diseases | Active | 04-Oct-2018 | ||
US-20210340278-A1 | Methods and pharmaceutical composition for the treatment of mucosal inflammatory diseases | Pending | 04-Oct-2018 | ||
JP-7592585-B2 | Methods and pharmaceutical compositions for the treatment of mucosal inflammatory diseases | Active | 04-Oct-2018 | ||
US-20200318203-A1 | Method of selection of an ire1-inhibitor therapy for patient suffering from cancer | Active | 20-Dec-2017 | C12Q1/6886 |
e-NIOS Signals
e-NIOS Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Pfizer (Pharmaceuticals) | Corporation | |||
IQbility | Accelerator/Incubator | Minority | ||
PJ Tech Catalyst | Venture Capital | Minority |
e-NIOS FAQs
-
When was e-NIOS founded?
e-NIOS was founded in 2013.
-
Where is e-NIOS headquartered?
e-NIOS is headquartered in Athens, Greece.
-
What is the size of e-NIOS?
e-NIOS has 8 total employees.
-
What industry is e-NIOS in?
e-NIOS’s primary industry is Drug Discovery.
-
Is e-NIOS a private or public company?
e-NIOS is a Private company.
-
What is e-NIOS’s current revenue?
The current revenue for e-NIOS is
. -
How much funding has e-NIOS raised over time?
e-NIOS has raised $367K.
-
Who are e-NIOS’s investors?
Pfizer (Pharmaceuticals), IQbility, and PJ Tech Catalyst have invested in e-NIOS.
-
Who are e-NIOS’s competitors?
SOPHiA GENETICS, Qiagen, and Roche Diagnostics are competitors of e-NIOS.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »